相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。miRNAs and ovarian cancer: a miRiad of mechanisms to induce cisplatin drug resistance
Priya Samuel et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2016)
MicroRNA let-7a Modifies the Effect of Self-Renewal Gene HIWI on Patient Survival of Epithelial Ovarian Cancer
Lingeng Lu et al.
MOLECULAR CARCINOGENESIS (2016)
Over-expression of miR-31 or loss of KCNMA1 leads to increased cisplatin resistance in ovarian cancer cells
Priya Samuel et al.
TUMOR BIOLOGY (2016)
The Dualistic Model of Ovarian Carcinogenesis Revisited, Revised, and Expanded
Robert J. Kurman et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
BRCA somatic mutations and epigenetic BRCA modifications in serous ovarian cancer
M. Moschetta et al.
ANNALS OF ONCOLOGY (2016)
Cancer Screening in the United States, 2016: A Review of Current American Cancer Society Guidelines and Current Issues in Cancer Screening
Robert A. Smith et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
LIN-28B/let-7a/IGF-II axis molecular subtypes are associated with epithelial ovarian cancer prognosis
Lingeng Lu et al.
GYNECOLOGIC ONCOLOGY (2016)
Molecular classification of high grade endometrioid and clear cell ovarian cancer using TCGA gene expression signatures
Boris Winterhoff et al.
GYNECOLOGIC ONCOLOGY (2016)
Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
Ian J. Jacobs et al.
LANCET (2016)
Utility of Serum miR-125b as a Diagnostic and Prognostic Indicator and Its Alliance with a Panel of Tumor Suppressor Genes in Epithelial Ovarian Cancer
Mariyam Zuberi et al.
PLOS ONE (2016)
Evidence for a Dualistic Model of High-grade Serous Carcinoma BRCA Mutation Status, Histology, and Tubal Intraepithelial Carcinoma
Brooke E. Howitt et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
A novel serum microRNA panel to discriminate benign from malignant ovarian disease
Ream Langhe et al.
CANCER LETTERS (2015)
miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma
Tae Hoen Kim et al.
CANCER LETTERS (2015)
FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of Chemotherapy
Geoffrey Kim et al.
CLINICAL CANCER RESEARCH (2015)
Have we given up on a cure for ovarian cancer?
S. A. Narod
CURRENT ONCOLOGY (2015)
The passenger strand, miR-21-3p, plays a role in mediating cisplatin resistance in ovarian cancer cells
Ryan Charles Pink et al.
GYNECOLOGIC ONCOLOGY (2015)
Augmentation of Response to Chemotherapy by microRNA-506 Through Regulation of RAD51 in Serous Ovarian Cancers
Guoyan Liu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial
Amit M. Oza et al.
LANCET ONCOLOGY (2015)
Evaluation of Cell-Free Urine microRNAs Expression for the Use in Diagnosis of Ovarian and Endometrial Cancers. A Pilot Study
Ludek Zavesky et al.
PATHOLOGY & ONCOLOGY RESEARCH (2015)
Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway
Shuo Chen et al.
PLOS ONE (2015)
Serum microRNA-145 as a novel biomarker in human ovarian cancer
Huichao Liang et al.
TUMOR BIOLOGY (2015)
Augmentation of Response to Chemotherapy by microRNA-506 Through Regulation of RAD51 in Serous Ovarian Cancers
Guoyan Liu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
The Global Burden of Cancer 2013 Global Burden of Disease Cancer Collaboration
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2015)
Harnessing pandemonium: the clinical implications of tumor heterogeneity in ovarian cancer
Sarah P. Blagden
FRONTIERS IN ONCOLOGY (2015)
MiR-506 inhibits multiple targets in the epithelial-to-mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer
Yan Sun et al.
JOURNAL OF PATHOLOGY (2015)
The BRCA1/2-directed miRNA signature predicts a good prognosis in ovarian cancer patients with wild-type BRCA1/2
Yunyan Gu et al.
ONCOTARGET (2015)
Biological properties of extracellular vesicles and their physiological functions
Maria Yanez-Mo et al.
JOURNAL OF EXTRACELLULAR VESICLES (2015)
The heterogeneity of ovarian cancer
I. Meinhold-Heerlein et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2014)
Differential microRNA Expression by Solexa Sequencing in the Sera of Ovarian Cancer Patients
Ting Ji et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker
Bente Vilming Elgaaen et al.
BMC CANCER (2014)
Circulating biomarkers for detection of ovarian cancer and predicting cancer outcomes
I. Shapira et al.
BRITISH JOURNAL OF CANCER (2014)
Epithelial-mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: Prognostic value and prospective role in ovarian cancer therapeutics
Maria Koutsaki et al.
CANCER LETTERS (2014)
Exosome-derived miRNAs and ovarian carcinoma progression
Olga Vaksman et al.
CARCINOGENESIS (2014)
Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas
Kathryn P. Pennington et al.
CLINICAL CANCER RESEARCH (2014)
Down-regulated miR-22 as predictive biomarkers for prognosis of epithelial ovarian cancer
Wei-na Wan et al.
DIAGNOSTIC PATHOLOGY (2014)
Involvement of miR-29b signaling in the sensitivity to chemotherapy in patients with ovarian carcinoma
Furong Dai et al.
HUMAN PATHOLOGY (2014)
Staging classification for cancer of the ovary, fallopian tube, and peritoneum
Jaime Prat
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2014)
Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer
Gottfried E. Konecny et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
MicroRNAs as prognostic markers in ovarian cancer
Marta Llaurado et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Regulation of microRNA biogenesis
Minju Ha et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
The Role of BRCA Status on the Prognosis of Patients with Epithelial Ovarian Cancer: A Systematic Review of the Literature with a Meta-Analysis
Chaoyang Sun et al.
PLOS ONE (2014)
MicroRNA-150 Predicts a Favorable Prognosis in Patients with Epithelial Ovarian Cancer, and Inhibits Cell Invasion and Metastasis by Suppressing Transcriptional Repressor ZEB1
Minfei Jin et al.
PLOS ONE (2014)
MiR-212 exerts suppressive effect on SKOV3 ovarian cancer cells through targeting HBEGF
Li-qiang Wei et al.
TUMOR BIOLOGY (2014)
miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma
Ruifen Dong et al.
ONCOTARGET (2014)
Routes and mechanisms of extracellular vesicle uptake
Laura Ann Mulcahy et al.
JOURNAL OF EXTRACELLULAR VESICLES (2014)
Pre-profiling factors influencing serum microRNA levels
Sara A. MacLellan et al.
BMC CLINICAL PATHOLOGY (2014)
Identification of Serum MicroRNA-21 as a Biomarker for Early Detection and Prognosis in Human Epithelial Ovarian Cancer
Yun-Zhao Xu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
BRAF Mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer
Rachel N. Grisham et al.
CANCER (2013)
miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities
Enrica Calura et al.
CLINICAL CANCER RESEARCH (2013)
Plasma MicroRNAs as Novel Biomarkers for Endometriosis and Endometriosis-Associated Ovarian Cancer
Swati Suryawanshi et al.
CLINICAL CANCER RESEARCH (2013)
MicroRNAs as therapeutic targets in chemoresistance
Michela Garofalo et al.
DRUG RESISTANCE UPDATES (2013)
Detection of MicroRNA as Novel Biomarkers of Epithelial Ovarian Cancer From the Serum of Ovarian Cancer Patient
Ye-Won Chung et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2013)
Serum microRNA-92 expression in patients with ovarian epithelial carcinoma
Fengjun Guo et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2013)
Prognostic significance of serum microRNA-221 expression in human epithelial ovarian cancer
Fanzhen Hong et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2013)
The Imprinted H19 LncRNA Antagonizes Let-7 MicroRNAs
Amanda N. Kallen et al.
MOLECULAR CELL (2013)
Biomarker Testing for Ovarian Cancer: Clinical Utility of Multiplex Assays
Brian M. Nolen et al.
MOLECULAR DIAGNOSIS & THERAPY (2013)
Meta-Analysis Using a Novel Database, miRStress, Reveals miRNAs That Are Frequently Associated with the Radiation and Hypoxia Stress-Responses
Laura Ann Jacobs et al.
PLOS ONE (2013)
Plasma miRNAs as Diagnostic and Prognostic Biomarkers for Ovarian Cancer
Hong Zheng et al.
PLOS ONE (2013)
A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis
Andrea Vecchione et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Nanoparticle analysis of circulating cell-derived vesicles in ovarian cancer patients
Cicek Gercel-Taylor et al.
ANALYTICAL BIOCHEMISTRY (2012)
Optimal first-line treatment in ovarian cancer
F. A. Raja et al.
ANNALS OF ONCOLOGY (2012)
Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer
Casina W. S. Kan et al.
BMC CANCER (2012)
A Combined Array-Based Comparative Genomic Hybridization and Functional Library Screening Approach Identifies mir-30d As an Oncomir in Cancer
Ning Li et al.
CANCER RESEARCH (2012)
MicroRNAs in Stress Signaling and Human Disease
Joshua T. Mendell et al.
CELL (2012)
Exosomes: New players in cell-cell communication
Claudia Bang et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
Prognostic Value of Residual Tumor Size in Patients With Epithelial Ovarian Cancer FIGO Stages IIA-IV Analysis of the OVCAD Data
Stephan Polterauer et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2012)
Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer
Kelly L. Bolton et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma
Robert A. Soslow et al.
MODERN PATHOLOGY (2012)
Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2
A. Chao et al.
ONCOGENE (2012)
Molecular mechanisms of cisplatin resistance
L. Galluzzi et al.
ONCOGENE (2012)
MicroRNA Genes and Their Target 3′-Untranslated Regions Are Infrequently Somatically Mutated in Ovarian Cancers
Georgina L. Ryland et al.
PLOS ONE (2012)
MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features
Heejeong Lee et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2012)
Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients
P. M. L. H. Vencken et al.
ANNALS OF ONCOLOGY (2011)
Evaluation of two commercial global miRNA expression profiling platforms for detection of less abundant miRNAs
Steffen G. Jensen et al.
BMC GENOMICS (2011)
The miR-200 family controls β-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients
Susanna Leskelae et al.
ENDOCRINE-RELATED CANCER (2011)
MicroRNA let-7a: A potential marker for selection of paclitaxel in ovarian cancer management
Lingeng Lu et al.
GYNECOLOGIC ONCOLOGY (2011)
Effect of Screening on Ovarian Cancer Mortality The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial
Saundra S. Buys et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections
Sergio Marchini et al.
LANCET ONCOLOGY (2011)
Evolution of platinum resistance in high-grade serous ovarian cancer
Susanna L. Cooke et al.
LANCET ONCOLOGY (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Effectiveness of a Multivariate Index Assay in the Preoperative Assessment of Ovarian Tumors
Frederick R. Ueland et al.
OBSTETRICS AND GYNECOLOGY (2011)
Identification of a chrXq27.3 microRNA cluster associated with early relapse in advanced stage ovarian cancer patients
Marina Bagnoli et al.
ONCOTARGET (2011)
Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening
S. F. M. Haeusler et al.
BRITISH JOURNAL OF CANCER (2010)
Frequent Downregulation of miR-34 Family in Human Ovarian Cancers
David C. Corney et al.
CLINICAL CANCER RESEARCH (2010)
Deregulation of miR-519a, 153, and 485-5p and its clinicopathological relevance in ovarian epithelial tumours
Tae Heon Kim et al.
HISTOPATHOLOGY (2010)
A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
Laura Poliseno et al.
NATURE (2010)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
Pluripotent factor lin-28 and its homologue lin-28b in epithelial ovarian cancer and their associations with disease outcomes and expression of let-7a and IGF-II
Lingeng Lu et al.
EUROPEAN JOURNAL OF CANCER (2009)
A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer
Xiaoxia Hu et al.
GYNECOLOGIC ONCOLOGY (2009)
A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
Richard G. Moore et al.
GYNECOLOGIC ONCOLOGY (2009)
Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients
Ram Eitan et al.
GYNECOLOGIC ONCOLOGY (2009)
The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform
Kimberly E. Resnick et al.
GYNECOLOGIC ONCOLOGY (2009)
miR-29b Expression Is Associated With Disease-Free Survival in Patients With Ovarian Serous Carcinoma
Richard Flavin et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2009)
HOXA10 is Overexpressed in Human Ovarian Clear Cell Adenocarcinoma and Correlates With Poor Survival
Bin Li et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2009)
MicroRNAs in Cancer: Small Molecules With a Huge Impact
Marilena V. Iorio et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
MicroRNA Microarray Identifies Let-7i as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian Cancer
Nuo Yang et al.
CANCER RESEARCH (2008)
MicroRNA expression profiling in human ovarian cancer:: miR-214 induces cell survival and cisplatin resistance by targeting PTEN
Hua Yang et al.
CANCER RESEARCH (2008)
Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma
Hiroaki Itamochi et al.
CANCER SCIENCE (2008)
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome
Richard W. Tothill et al.
CLINICAL CANCER RESEARCH (2008)
MicroRNA expression profiles in serous ovarian carcinoma
Eun Ji Nam et al.
CLINICAL CANCER RESEARCH (2008)
被撤回的出版物: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer (Retracted article. See vol. 175, pg. 192, 2023)
Douglas D. Taylor et al.
GYNECOLOGIC ONCOLOGY (2008)
Potential role of miR-9 and miR-223 in recurrent ovarian cancer
Alexandros Laios et al.
MOLECULAR CANCER (2008)
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers
Johan Skog et al.
NATURE CELL BIOLOGY (2008)
MicroRNA Expression and Identification of Putative miRNA Targets in Ovarian Cancer
Neetu Dahiya et al.
PLOS ONE (2008)
Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer
Lin Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Circulating microRNAs as stable blood-based markers for cancer detection
Patrick S. Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
Martin Koebel et al.
PLOS MEDICINE (2008)
Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis
Lingeng Lu et al.
CANCER RESEARCH (2007)
MicroRNA signatures in human ovarian cancer
Marilena V. Iorio et al.
CANCER RESEARCH (2007)
Let-7 expression defines two differentiation stages of cancer
Scott Shell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Differences of chemoresistance assay between invasive micropapillary/low-grade serous ovarian carcinoma and high-grade serous ovarian carcinoma
A. Santillan et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2007)
CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients - From The Danish MALOVA Ovarian Cancer Study
Estrid V. S. Hogdall et al.
GYNECOLOGIC ONCOLOGY (2007)
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells
Hadi Valadi et al.
NATURE CELL BIOLOGY (2007)
Exosomes biological significance: A concise review
RM Johnstone
BLOOD CELLS MOLECULES AND DISEASES (2006)
Cancer of the ovary
SA Cannistra
NEW ENGLAND JOURNAL OF MEDICINE (2004)
A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer
A du Bois et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma
G Singer et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
分享论文
